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Abstract. 
 
The folding and trafficking of tropoelastin is 
thought to be mediated by intracellular chaperones, 
although the identity and role of any tropoelastin chap-
erone remain to be determined. To identify proteins 
that are associated with tropoelastin intracellularly, bi-
functional chemical cross-linkers were used to co-
valently stabilize interactions between tropoelastin and 
associated proteins in the secretory pathway in intact 
fetal bovine auricular chondrocytes. Immunoprecipi-
tation of tropoelastin from cell lysates after cross-link-
ing and analysis by SDS-PAGE showed the presence of 
 
two proteins of 
 
z
 
74 kD (p74) and 78 kD (p78) that 
coimmunoprecipitated with tropoelastin. Microse-
quencing of peptide fragments from a cyanogen bromide 
digest of p78 identified this protein as BiP and se-
quence analysis identified p74 as the peptidyl-prolyl 
 
cis–trans
 
 isomerase, FKPB65. The appearance of BiP 
and FKBP65 in the immunoprecipitations could be 
enhanced by the addition of brefeldin A (BFA) and 
 
N
 
-acetyl-leu-leu-norleucinal (ALLN) to the culture 
medium for the final 4 h of labeling. Tropoelastin accu-
mulates in the fused ER/Golgi compartment in the 
presence of BFA if its degradation is inhibited by 
ALLN (Davis, E.C., and R.P. Mecham. 1996. 
 
J. Biol. 
Chem.
 
 271:3787–3794). The use of BFA and other se-
cretion-disrupting agents suggests that the association 
of tropoelastin with FKBP65 occurs in the ER. Results 
from this study provide the first identification of a 
ligand for an FKBP in the secretory pathway and sug-
gest that the prolyl 
 
cis–trans
 
 isomerase activity of 
FKBP65 may be important for the proper folding of the 
proline-rich tropoelastin molecule before secretion.
 
T
 
ropoelastin 
 
is a soluble 70-kD protein that is
cross-linked in the presence of extracellular mi-
crofibrils to form insoluble elastic fibers. These fi-
bers are an abundant component of the extracellular ma-
trix where they provide the critical function of elasticity to
tissues such as blood vessels, lung, and skin (Mecham and
Davis, 1994). Apart from cleavage of a signal sequence as the
completed polypeptide chain enters the ER (Karr and Fos-
ter, 1981; Saunders and Grant, 1984; Grosso and Mecham,
1988), the tropoelastin monomer remains relatively un-
changed as it traverses the secretory pathway en route to the
cell surface, with no glycosylation or proteolytic processing.
In a previous study, we reported that tropoelastin un-
dergoes selective degradation in the ER as a consequence
of being retained in that compartment by brefeldin A
(BFA)
 
1
 
 treatment (Davis and Mecham, 1996). Similar to
other proteins that undergo ER-associated degradation
(Inoue et al., 1991; Wileman et al., 1991; Thrift et al.,
1992), the degradation of tropoelastin can be inhibited by
the cysteine protease inhibitor, 
 
N
 
-acetyl-leu-leu-norleuci-
nal (ALLN). Because tropoelastin has the property of be-
ing able to undergo a phase transition and form a coacer-
vate when at high concentrations under physiological
conditions (Cox et al., 1974), it was postulated that the ac-
cumulation of tropoelastin within the fused ER/Golgi
compartment during BFA treatment may lead to coacer-
vation of the protein and thus its subsequent recognition
and degradation as a misfolded protein. Consistent with
this hypothesis was the observation of a lag period during
which time tropoelastin accumulated for 1 h before rapid
degradation of the protein (Davis and Mecham, 1996).
The increased concentration of tropoelastin in the fused
ER/Golgi compartment may also exhaust an existing sup-
ply of chaperones that would normally fold and traffic tro-
poelastin to the Golgi, again leading to misfolding and
degradation. A protective function for an ER chaperone
has been suggested by the work of Jain and colleagues
(1994) who demonstrated that the interaction of procol-
lagen I with the ER chaperone, colligin/hsp47, protects the
molecule from degradation by a serine protease in the ER.
Because the expression of hsp47 predominates in col-
lagen-secreting cells (Saga et al., 1987) and its synthesis
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1. 
 
Abbreviations used in this paper
 
: ALLN, 
 
N
 
-acetyl-leu-leu-norleucinal;
BFA, brefeldin A; CNBr, cyanogen bromide; DSP, dithiobis-(succini-
midyl propionate); DSS, disuccinimidyl suberate; ECL, enhanced chemilu-
minescence; FBCs, fetal bovine chondrocytes; OPA, 
 
o
 
-phthalaldehyde;
PPIase, peptidyl-prolyl 
 
cis–trans
 
 isomerase.
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closely correlates to that of collagen under many condi-
tions (Clarke et al., 1993), the possibility has been raised
that a population of molecular chaperones may exist that
are specific for certain substrates (Nagata, 1996).
To investigate the possibility of “substrate-specific”
chaperones, primary cultures of fetal bovine chondrocytes
were studied for the presence of potential molecular chap-
erones for tropoelastin. In culture, tropoelastin is a major
protein produced by these cells, and is secreted and assem-
bled into an insoluble extracellular elastin matrix. Using
the membrane permeable chemical cross-linkers dithiobis-
(succinimidyl propionate) (DSP) and disuccinimidyl su-
berate (DSS), we have identified two proteins that coim-
munoprecipitate with tropoelastin under cross-linking
conditions in intact cells. Sequence analysis of these pro-
teins has identified them as the ER chaperone BiP and the
65-kD FK506-binding protein FKPB65. FKBP65 is a
member of the highly conserved family of intracellular re-
ceptors called immunophilins (Schreiber, 1991; Sigal and
Dumont, 1992; Galat, 1993). Based on their ability to bind
either of the two immunosuppressant drugs, cyclosporin A
or FK506, the immunophilins have been divided into two
groups, cyclophilins and FKBPs, respectively. To date, six
members of the FKBP family have been identified and
named according to their respective molecular weights:
FKBP12 (Harding et al., 1989; Siekierka et al., 1989),
FKBP13 (Jin et al., 1991), FKBP25 (Galat et al., 1992; Jin
et al., 1992; Wiederrecht et al., 1992), FKBP52 (Peattie et
al., 1992), FKBP54 (Smith et al., 1993) and, most recently,
FKBP65 (Coss et al., 1995). Of these, only FKBP13 has
been specifically localized to the ER (Nigam et al., 1993).
The presence of a putative signal sequence, glycosylation
sites and an ER retention sequence (HEEL; Pelham,
1990) at the COOH terminus of FKBP65 (Coss et al.,
1995), however, predicts that this protein will also be con-
tained within the ER.
Apart from the property of peptidyl-prolyl 
 
cis–trans
 
isomerization, which is common to all immunophilins, no
specific function or ligand for FKBPs in the ER has been
identified. Results from this study thus provide the first
identification of a ligand for an FKBP in the secretory
pathway. That this ligand is tropoelastin, a protein with a
large percentage of proline residues, suggests that the pro-
lyl isomerase activity of FKBP65 may be important for
tropoelastin folding, trafficking, and ultimate assembly
into elastic fibers.
 
Materials and Methods
 
Cells and Reagents
 
Bovine ears were obtained from fetuses of 160–180 d of gestation at a lo-
cal slaughterhouse. Fetal bovine chondrocytes (FBCs) were obtained by
collagenase digestion of the auricular cartilage as previously described
(Mecham, 1987). All experiments were conducted with first passage cells
grown in Dulbecco’s modified Eagle’s medium supplemented with 
 
l
 
-glu-
tamine, nonessential amino acids, antibiotics, and 10% fortified bovine
calf serum (Hyclone, Logan, UT).
For metabolic labeling, [4,5-
 
3
 
H]
 
l
 
-leucine (1 mCi/ml) and [
 
35
 
S]
 
l
 
-cys-
teine, (10 mCi/ml) were purchased from ICN Biomedicals, Inc. (Irvine,
CA) and Pro-mix 
 
l
 
-[
 
35
 
S] in vivo cell labeling mix (14.3 mCi/ml) was pur-
chased from Amersham Corp. (Arlington Heights, IL). Dialyzed FBS was
purchased from Hyclone. Protease inhibitors, 
 
e
 
-amino-
 
n
 
-caproic acid,
phenylmethylsulfonyl fluoride, ethylenediamine-tetraacetic acid, and
 
N
 
-ethylmaleimide were purchased from Sigma Chemical Co. (St. Louis,
MO) and used in the lysis buffer at final concentrations of 10 mM, 2.5 mM,
5 mM, and 5 mM, respectively. Immune complexes were precipitated us-
ing a 1:1 slurry of protein A immobilized on Trisacryl (Pierce, Rockford,
IL) in lysis buffer.
Reagents used during metabolic labeling included ALLN, BFA, mon-
ensin, and bafilomycin A1 (Sigma Chemical Co.). ALLN and BFA were
both used at a final concentration of 10 
 
m
 
g/ml from 10 mg/ml stocks stored
at 
 
2
 
20
 
8
 
C in ethanol or DMSO, respectively. Monensin was prepared fresh
as a 10-mM stock in ethanol and used at a final concentration of 10 
 
m
 
M.
Bafilomycin A1 was stored at 
 
2
 
20
 
8
 
C as 100 
 
m
 
M stock in DMSO and used
at a final concentration of 1 
 
m
 
M. For chemical cross-linking, DSP and DSS
were purchased from Pierce and made fresh as 0.1 M stocks in DMSO im-
mediately before use.
 
Antibodies
 
For immunoprecipitation experiments and Western blot analysis, a mono-
clonal tropoelastin antibody, BA-4, raised to bovine 
 
a
 
-elastin (Wrenn et al.,
1986) and a polyclonal FKBP65 antipeptide antibody were used. For pro-
duction of the FKBP65 antibody, a synthetic peptide to the COOH termi-
nus of mouse FKBP65 (Coss et al., 1995) was prepared using FastMoc
chemistry on an ABI 431A peptide synthesizer. The sequence of the pep-
tide was confirmed using an ABI 473 protein sequencer. The peptide
made was C-LKSDEDQERVHEEL and thus targets the same antigenic
epitope as the Pep 4 antibody prepared by Coss and colleagues (Coss et al.,
1995). Antibody production from the synthetic peptide was performed as
previously described (Mariencheck et al., 1995). The antibody was used as
an IgG fraction without further purification.
 
Metabolic Labeling and Chemical Cross-linking
 
Confluent monolayers of FBCs, grown in P-100 tissue culture plates, were
washed with leucine-free or cysteine/methionine-free medium containing
5% dialyzed FBS and incubated in this medium for 1 h. Each dish of cells
was metabolically labeled with either 50 
 
m
 
Ci of [
 
3
 
H]leucine in 3 ml of leu-
cine-free medium containing 5% dialyzed FBS for tropoelastin labeling,
or 60 
 
m
 
Ci of [
 
35
 
S]cysteine plus 60 
 
m
 
Ci of [
 
35
 
S]Pro-mix in cysteine/methion-
ine-free medium for labeling of cross-linked proteins. Any treatment of
cells during the pulse with BFA, ALLN, monensin, or bafilomycin A1 is
as indicated in the text and figure legends. After metabolic labeling, the
medium was removed and cell layers were washed with room temperature
PBS. To each dish, 1 ml of PBS was added and the cell layers scraped up,
transferred to microfuge tubes, and pelleted at 1,000 
 
g.
 
 The cell pellets
were then resuspended in 100 
 
m
 
l of PBS and 2 
 
m
 
l of either DSP stock, DSS
stock, or DMSO (carrier), was added. Cross-linking was carried out at
room temperature with periodic gentle vortexing. After 45 min, 900 
 
m
 
l of
PBS was added to each tube and the cross-linking reaction was quenched
by the addition of 20 
 
m
 
l/ml of a 1-M glycine stock (pH 9.2). The samples
were vortexed and left at room temperature for 10 min before the addi-
tion of 10 
 
m
 
l/ml of a 1-M glycine stock (pH 7.2) to lower the pH. After a
wash in PBS, 1 ml of cold lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM
NaCl, 1% NP-40) with protease inhibitors was added to each tube and the
tubes were rotated at 4
 
8
 
C for 30 min. Cellular debris was pelleted by cen-
trifugation and the cell lysates transferred to clean microfuge tubes for im-
munoprecipitation.
 
Sucrose Density Gradient Analysis
 
For analysis of DSP cross-linked complexes, two P-100 culture dishes of
postconfluent FBCs were metabolically labeled with [
 
35
 
S]cysteine and
[
 
35
 
S]Pro-mix for 18 h, chemically cross-linked with DSP, and then lysed as
described above. The lysate (1 ml) was precleared by incubation with 10
 
m
 
g/ml normal mouse IgG for 2 h followed by an additional hour with 25 
 
m
 
l
of protein A immobilized on Trisacryl. The protein A–Trisacryl was pel-
leted by centrifugation and the lysate was layered over a 10-ml gradient of
5–25% sucrose prepared with a buffer of 50 mM Tris-HCl (pH 8.0) con-
taining 150 mM NaCl and 0.1% Triton X-100. The gradient was spun in a
Beckman SW-41 rotor at 288,000 
 
g
 
 for 34 h at 4
 
8
 
C. After centrifugation, 32
fractions of 350 
 
m
 
l each were collected from the top of the gradient and
immunoprecipitated for tropoelastin as described below.
 
Immunoprecipitation
 
Lysates were precleared by incubation with 10 
 
m
 
g/ml normal mouse IgG
for 2 h followed by an additional hour with 25 
 
m
 
l of protein A immobilized 
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on Trisacryl. The protein A–Trisacryl was pelleted by centrifugation and
the supernatants transferred to clean tubes containing 100 
 
m
 
l of 50 mg/ml
BSA in lysis buffer and 10 
 
m
 
g of BA-4 antibody or 50 
 
m
 
g of FKBP65 anti-
body. Lysates were incubated overnight at 4
 
8
 
C with gentle agitation. The
following day, 40 
 
m
 
l of protein A–Trisacryl was added to each tube and in-
cubated for 1 h at 4
 
8
 
C with gentle agitation. The immune complexes were
pelleted and the pellets washed three times with 50 mM Tris-HCl, and
400 mM NaCl (pH 8.0), and one time with 10 mM Tris-HCl (pH 6.8). Af-
ter the final wash, each pellet was resuspended in 35 
 
m
 
l of Laemmli sam-
ple buffer containing DTT and incubated at 100
 
8
 
C for 6 min. The samples
were electrophoresed on SDS-polyacrylamide gels and then fixed and
treated with EN
 
3
 
HANCE (NEN Research Products, Boston, MA) for 1 h
for 
 
3
 
H-containing gels and 1 M salicylic acid in 15% methanol for 30 min
for 
 
35
 
S-containing gels. Gels were then dried and exposed to Kodak XAR-5
X-ray film. Exposure times were 
 
z
 
24 h for all gels except the sucrose den-
sity gradient (Fig. 3) that was exposed for 2 wk. All immunoprecipitation
experiments were conducted a minimum of three times to ensure repro-
ducibility of results. For densitometric quantitation, autoradiographic
bands were scanned using NIH image. Each band for each of the three
proteins was scanned four times with different sized areas to ensure accu-
rate and consistent measurements. The same four areas were used for
each experimental condition. The average of the four measurements was
plotted.
 
Western Blot Analysis
 
After electrophoresis, cross-linked samples were transferred to nitrocellu-
lose and nonspecific-binding sites were blocked with 5% dry milk in TBS
(20 mM Tris base, 137 mM NaCl [pH 7.6]) containing 0.1% Tween-20
overnight at 4
 
8
 
C. All remaining rinses, washes, and antibody dilutions
were in 2% dry milk, 0.05% Tween-20 in TBS. The next day, the blot was
rinsed and incubated in primary antibody for 1 h. After two quick rinses
and 1 
 
3
 
 15 min and 2 
 
3
 
 5 min washes, the blot was then incubated for 1 h
with HRP-linked sheep anti–mouse F(ab
 
9
 
)
 
2
 
 (Amersham Corp.) for detec-
tion of tropoelastin, or HRP-linked donkey anti–rabbit F(ab
 
9
 
)
 
2
 
 for detec-
tion of FKBP65. After a wash, as described above, and final rinse in TBS,
the blot was incubated with enhanced chemiluminescence (ECL) detec-
tion reagents (Amersham Corp.) according to the manufacturer’s direc-
tions.
 
Cyanogen Bromide Treatment and Microsequencing
 
To obtain sufficient protein for microsequencing, tropoelastin was immu-
noprecipitated from FBCs in six P-100 culture dishes after cross-linking
with DSP, as described above. The sample was loaded in a single lane,
electrophoresed, and transferred to ProBlott membrane (Applied Biosys-
tems Inc., Foster City, CA) according to the manufacturer’s directions.
After the transfer, the membrane was rinsed in several changes of distilled
water, stained with 0.1% Coomassie blue R-250 in 50% methanol for 2
min, and destained with several changes of 50% methanol containing 10%
acetic acid. The membrane was then rinsed with several changes of distilled
water and air dried. Each band to be sequenced was excised from the dry
membrane, cut into 2–3 mm
 
2
 
 pieces and placed in a microfuge tube. To
each tube, 150 
 
m
 
l of 150 mM cyanogen bromide (CNBr) in 70% (vol/vol)
formic acid was added and the tubes were incubated overnight in the dark
at room temperature. Excess reagent was removed by vacuum centrifuga-
tion, and when dry, the slices were washed with 50 
 
m
 
l deionized water by
vortexing and redried. The dried pieces of the blot were then loaded into
the reaction chamber of an ABI 473 protein sequencer for sequence anal-
ysis. Sequence obtained from the CNBr digest was confirmed with the
 
o
 
-phthalaldehyde (OPA) blocking technique (Brown-Augsburger et al.,
1995), a way of sequencing a single peptide in a peptide mixture.
 
Results
 
To identify molecular chaperones that assist in the secre-
tion and assembly of tropoelastin, FBCs were chosen be-
cause these cells continue to synthesize and secrete tro-
poelastin monomers when established in primary culture.
Unlike many elastogenic cell types, FBCs in culture also
assemble the monomers into an insoluble extracellular
elastic fiber (Lee et al., 1994). It is hypothesized, therefore,
that within these cells, the protein must associate with an
 
appropriate series of folding and trafficking chaperones to
allow for ultimate assembly outside the cell.
 
Tropoelastin Is Cross-linked into Higher Molecular 
Weight Complexes by DSS
 
Because tropoelastin is rapidly secreted (Davis and Me-
cham, 1996), initial experiments were conducted with BFA
to accumulate the protein within the cell and allow for
maximal interaction with potential molecular chaperones.
In all instances, the cysteine protease inhibitor ALLN was
included with BFA to inhibit the selective degradation of
tropoelastin that occurs as a result of its retention in the
fused ER/Golgi compartment (Davis and Mecham, 1996).
With an abundance of leucine residues, and only two cys-
teines and no methionines, [
 
3
 
H]leucine was used to meta-
bolically label tropoelastin in FBCs for 4 h in the presence
of BFA and ALLN. After cross-linking with DSP, immu-
noprecipitation of tropoelastin from the cell lysate re-
vealed one wide band at 
 
z
 
70 kD upon separation by SDS-
PAGE under reducing conditions (Fig. 1 
 
A
 
). Two isoforms
of tropoelastin are expressed by these cells, thus the wide
band actually represents a doublet (see Figs. 4 
 
A
 
 and 6).
When the nonreducible cross-linker DSS was used, the
tropoelastin band was reduced in density and four addi-
tional high molecular weight bands were evident (Fig. 1 
 
A
 
).
To determine if these bands represented tropoelastin mono-
mers cross-linked by DSS into higher molecular weight
complexes, the experiment was repeated under nonradio-
active conditions and the proteins were transferred and
probed for tropoelastin by Western analysis. As seen in
Fig. 1 
 
B
 
, the identical pattern of four bands was revealed
in the DSS sample, whereas no immunoreactive bands for
tropoelastin were observed in the DSP sample.
 
Metabolic Labeling with [
 
35
 
S]Cysteine/Methionine 
Reveals Two Proteins Cross-linked to Tropoelastin in 
the Secretory Pathway
 
Although tropoelastin was detected in high molecular
weight complexes after cross-linking with DSS, no addi-
tional protein(s) were evident on the autoradiograph in
the DSP cross-linked sample. It was assumed, therefore,
that the protein(s) to which tropoelastin was cross-linked
was not efficiently labeled. For this reason, the experiment
was repeated using [
 
35
 
S]cysteine/methionine as the radio-
label. To ensure that the cross-linking of tropoelastin to
another protein in the secretory pathway was not a brefel-
din A–induced event, the experiment was first conducted
in the absence of any secretion-disrupting drug. After
cross-linking with DSP, cell lysates immunoprecipitated for
tropoelastin demonstrated the presence of a thin, faint
band at 78 kD (p78) and a more prominent band at 74 kD
(p74) (Fig. 2 
 
A
 
). The band of tropoelastin at 70 kD was
barely discernible because tropoelastin is not well labeled
by [
 
35
 
S]cysteine/methionine. In the cell lysate from the
DSS cross-linked sample, no bands at these molecular
weights were observed, indicating that p74 and p78 were
cross-linked to tropoelastin in higher molecular weight
complexes.
In these experiments, tropoelastin was continually being
secreted during the 16-h labeling period, so the amount of
radiolabeled tropoelastin within the cell would be constant 
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and its association with any chaperone protein would be
relatively short-lived in control (untreated) cells. To retain
more tropoelastin inside the cell and potentially enhance
the association of tropoelastin with p74 and p78, FBCs
were labeled for 16 h with [
 
35
 
S]cysteine/methionine and
treated with BFA and ALLN during the final 4 h of the la-
beling period. Under these conditions, a prominent band
of tropoelastin was observed in the DSP cross-linked cell
lysates together with increased amounts of p74 and p78
(Fig. 2 
 
B
 
). This result suggests that the p74 and p78 pro-
teins are present with tropoelastin in the fused ER/Golgi
compartment. As expected with the nonreducible cross-
linker DSS, the tropoelastin band was reduced in amount
and higher molecular weight bands of cross-linked pro-
teins similar to those seen in Fig. 1 were observed. In addi-
tion, no p74 was observed in the DSS cross-linked lysate,
indicating that all of this protein was immunoprecipitated
by being cross-linked to tropoelastin. A small amount of
p78, however, was evident suggesting that some p78 could
be coimmunoprecipitated with tropoelastin without being
directly cross-linked to it. This is supported by the obser-
vation that a similar amount of p78 is seen in cell lysates
incubated with DMSO alone (Fig. 2 
 
B
 
).
 
Sedimentation Analysis of the DSP
Cross-linked Proteins
 
To investigate the nature of the tropoelastin complex and
associated proteins, a DSP cross-linked lysate was sedi-
mented over a 5–25% sucrose density gradient. Fractions
were collected, immunoprecipitated for tropoelastin, and
separated on a reducing gel. Fig. 3 shows that a consider-
able proportion of tropoelastin was present in the light
fractions. This indicates that a population of intracellular
tropoelastin was either not associated with any other pro-
tein in the cell or unaffected by this particular type of
cross-linker. This result is consistent with the presence of a
band of tropoelastin in immunoprecipitations of DSS cross-
linked lysates (Fig. 2 
 
B
 
). Although only weakly labeled by
the [
 
35
 
S]cysteine/methionine, tropoelastin was also ob-
Figure 1. Cross-linking of tropoelastin into higher molecular
weight complexes by DSS treatment. (A) Intact FBCs labeled for
4 h with [3H]leucine in the presence of BFA and ALLN were
cross-linked with either DSP or DSS and then lysed and immuno-
precipitated for tropoelastin. Analysis by SDS-PAGE under re-
ducing conditions showed higher molecular weight complexes in
the DSS-treated cells (arrows) and a reduced intensity of tro-
poelastin monomer at 70 kD (TE). (B) FBCs treated for 4 h with
BFA and ALLN were cross-linked, lysed, and immunoprecipi-
tated for tropoelastin. After SDS-PAGE, the proteins were
transferred to nitrocellulose and blotted for tropoelastin. Immu-
noreactive bands in the DSS lane (arrows) indicate nonreducible
cross-linked complexes of tropoelastin with other proteins. (PC)
pre-clear.
Figure 2. 35S-labeling allows the identification of two proteins
that are cross-linked to tropoelastin. FBCs were labeled with
[35S]cysteine/methionine for 16 h and (A) either left untreated
(CONTROL) or (B) treated with BFA and ALLN (BFA 1 ALLN)
for the final 4 h of the labeling period. After metabolic labeling,
intracellular proteins were cross-linked with either DSP or DSS,
lysed, and immunoprecipitated for tropoelastin. One of the BFA
1 ALLN samples was treated with an equivalent concentration
of DMSO alone (vehicle) rather than cross-linker. Analysis by
SDS-PAGE under reducing conditions showed the presence of
two additional bands in the DSP-treated cells (p74 and p78).
These bands were greatly enhanced after BFA-treatment. In the
DSS cross-linked lysates, high molecular weight bands in the
same position as were seen in Fig. 1 were observed (arrows), and
as expected, the immunoprecipitated bands of tropoelastin (TE),
p74 and p78, were all reduced in density. Note that p78 coimmu-
noprecipitates with tropoelastin in the absence of cross-linker. 
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served in the center of the gradient together with p74 and
p78. In addition, the sedimentation analysis showed sev-
eral other bands that distributed in the same fractions. In-
creasing evidence suggests that BiP may be part of a set of
resident ER chaperones that complex together with secre-
tory proteins as they fold and assemble in the ER (Lin et
al., 1993; Nigam et al., 1994; Kuznetsov et al., 1997). This
“folding complex” is reported to include BiP, ERp72,
grp94, and grp170. The molecular weights of two of the
bands that cosediment with the tropoelastin-p74–p78 com-
plex are similar to those expected for the two ER chaper-
ones, grp94 and grp170. The identity of these proteins,
however, remains to be determined. Note that the cells for
this experiment were not treated with BFA and ALLN at
the end of the labeling period. This provides evidence that
the association of p74 and p78 with tropoelastin occurs un-
der normal conditions of tropoelastin trafficking and is not
a consequence of BFA-induced accumulation of tropo-
elastin in the fused ER/Golgi compartment.
The Association of Tropoelastin with p74
and p78 Occurs within Early Compartments of the 
Secretory Pathway
The association of p74 and p78 with tropoelastin as it trav-
els through the secretory pathway was investigated by us-
ing several different secretion disrupting agents to block
the path of tropoelastin in various compartments within
the cell during the final 4 h of the labeling period. In con-
trol cells, a strong band of p74 and a diffuse band of p78
were observed in the DSP cross-linked sample despite the
tropoelastin band being barely evident (Fig. 4 A). This re-
sult is consistent with Fig. 2 A and confirms that the associ-
ation of tropoelastin with p74 and p78 occurs under normal
conditions when the trafficking of tropoelastin is unim-
peded. When BFA was used together with ALLN, there
was a concurrent increase in both the amount of tropoelas-
tin and associated proteins, p74 and p78, in the DSP cross-
linked cells as compared to untreated cells. Monensin,
which blocks transport of proteins from the cis to trans
side of the Golgi (Tartakoff, 1983), also resulted in a pro-
portional increase in both tropoelastin and the associated
proteins as determined by coimmunoprecipitation. Unlike
brefeldin A, monensin does not cause retrograde fusion of
the Golgi cisternae with the ER and thus the results ob-
tained indicate that the association of tropoelastin with
p74 and p78 is not induced by the brefeldin A alteration of
cell organelle architecture. In contrast to brefeldin A and
monesin, treatment of cells with bafilomycin A1 for the fi-
nal 4 h of the pulse did not enhance the amount of p74
or p78 that was cross-linked to tropoelastin over that ob-
tained in control cells despite more tropoelastin being im-
munoprecipitated under these conditions. This observation
was confirmed by densitometric scanning of the radiola-
beled bands (Fig. 4 B). Because bafilomycin A1 results in
the accumulation of secreted proteins at the level of the
trans-Golgi network (Henomatsu et al., 1993), these re-
sults suggest that both p74 and p78 are localized in early
compartments of the secretory pathway. Note that the use
of ALLN in the monensin and bafilomycin A1 incubations
was not necessary, as tropoelastin readily accumulates in
the Golgi without any apparent degradation by the ER-
associated, ALLN-sensitive mechanism (Davis, E.C., and
R.P. Mecham, manuscript submitted for publication).
Microsequence Analysis Identifies p78 as BiP and p74 
as Bovine FKBP65
The DSP cross-linked lysate was scaled up approximately
sixfold to obtain sufficient protein for microsequence anal-
ysis. After immunoprecipitation with the tropoelastin anti-
body, proteins were separated by SDS-PAGE and trans-
ferred to PVDF membrane. After staining with Coomassie
blue R-250, the p78 and p74 bands were easily recognized.
The p74 band, however, was diffuse and often appeared as
two bands (Fig. 5 A). Initial attempts to sequence protein
from these bands failed due to a blocked amino terminus,
most likely the consequence of the cross-linking reagent
Figure 3. Sedimentation anal-
ysis of DSP cross-linked pro-
tein complexes. Cells were
labeled with [35S]cysteine/
methionine for 18 h, cross-
linked with DSP, lysed, and
the lysate fractionated over
a 5–25% sucrose density gra-
dient. Fractions were immu-
noprecipitated for tropoelastin
and analyzed by SDS-PAGE
under reducing conditions and
fluorography (2 wk exposure).
Two pools of tropoelastin
are evident; a population not
cross-linked by DSP (frac-
tions  6–10) and a second pop-
ulation cross-linked to p74
and p78 (fractions 14–24).
Note that two additional
bands are seen to codistrib-
ute with the tropoelastin-
p74–p78 in the center of the
gradient (arrowheads).The Journal of Cell Biology, Volume 140, 1998 300
interacting with the a amino group. To obtain internal se-
quence, the p74 and p78 bands were cut from the blot and
the proteins were cleaved in situ with CNBr. The resulting
peptide mixture was then sequenced and, as expected, mul-
tiple sequences were obtained for both proteins. For p78,
the definitive location of proline residues in the peptide
mixture was determined. Using additional bands of CNBr-
cleaved p78, the mixture was then sequenced again until a
proline residue was exposed at the amino terminus. OPA
was then used to selectively block the primary amines at
the ends of each peptide in the mixture. Because OPA
does not react with secondary amines, the peptide with the
NH2-terminal proline remained unblocked and could be
independently sequenced (Brown-Augsburger et al., 1995).
The resulting sequences from several proline-containing
peptides sequenced in this manner allowed the identifica-
tion of p78 as the ER chaperone, BiP.
Independent microsequencing after CNBr cleavage of
each of the two bands that form the p74 doublet showed
that both bands were the same protein. Remarkably, when
the CNBr digest of p74 was sequenced, a clear single se-
quence was distinguished against a minor background of
residues, even though the digest contained a peptide mix-
ture. The derived sequence was used to search GenBank/
EMBL/DDBJ and a high degree of homology was ob-
tained with the peptidyl-prolyl cis–trans isomerase (PPI-
ase) domains of the mouse FK506-binding protein, FKBP65
under accession number L07063 (Coss et al., 1995). From
the sequence of mouse FKBP65, it was evident that the
strong sequence that was obtained for p74 was a result of
the high degree of homology between the four PPIase do-
mains in FKBP65 (Fig. 5 B).
Tropoelastin Is Cross-linked to FKBP65 in the 
Secretory Pathway of FBCs
To detect FKBP65 in FBCs and investigate its association
with tropoelastin, a peptide antibody was made to the
COOH terminus of the protein using the published se-
quence of mouse FKBP65 (Coss et al., 1995). The association
of the two proteins was investigated by Western analysis
after cross-linking and immunoprecipitation. Immunoblot-
ting of DSP cross-linked lysates with the FKBP65 antibody
after immunoprecipitation with the same antibody showed
the doublet of FKBP65 at 74 kD and an additional band at
100 kD (Fig. 6). The appearance of FKBP65 as a doublet is
consistent with the studies of Coss and colleagues (1995).
The identity of the 100-kD protein that cross-reacts with
the antibody is unknown. When immunoprecipitation of
DSP cross-linked lysates was carried out with the tropo-
elastin antibody and subsequently blotted for FKBP65, a
prominent wide band was observed at a molecular weight
identical to that seen by blotting with the FKBP65 anti-
Figure 4. Effect of secretion-disrupting agents on the association
of p74 and p78 with tropoelastin. (A) FBCs were metabolically
labeled with [35S]cysteine/methionine for 16 h with either no
treatment (control) or treatment with BFA 1 ALLN, monensin,
or bafilomycin A1 for the final 4 h of the labeling period. After
cross-linking with either DSP or DSS, the cells were lysed and im-
munoprecipitated for tropoelastin. Samples were analyzed by
SDS-PAGE under reducing conditions. A concurrent increase in
p74 and p78 was observed along with tropoelastin in cells treated
with either BFA 1 ALLN or monensin. No increase in p74 and
p78 was observed in bafilomycin A1-treated cells as compared to
control cells despite an increase in tropoelastin. (B) Densitomet-
ric scanning of the bands in A confirm the lack of increased p74
and p78 coimmunoprecipitation in bafilomycin A1-treated cells.
Note that the amount of p74 and p78 decreases as the secretion
block moves progressively farther along the secretory pathway.
Figure 5. Microsequencing identifies p78 as BiP and p74 as bo-
vine FKBP65. (A) FBCs were treated with BFA 1 ALLN for 4 h,
cross-linked with DSP, lysed and immunoprecipitated using an
antibody to tropoelastin. Samples were separated by SDS-PAGE,
transferred to PVDF membrane, and stained with Coomassie
blue. Areas indicated on the right were cut from the blot and
treated with CNBr before sequencing. Unique sequences from
p78 obtain following OPA treatment identified p78 as BiP. Sepa-
rate sequencing of the two p74 bands following CNBr digestion
showed that both bands were the same protein. (B) Alignment of
the amino acid sequence from a portion of each of the four PPI-
ase domains in mouse FKBP65 as reported by Coss and col-
leagues (1995) with the sequence determined for p74 after CNBr
treatment. Note the high degree of homology between the PPIase
domains (bold) that allows a definitive sequence for p74 to be ob-
tained from the peptide mixture.Davis et al. Tropoelastin Binds FKBP65 in the ER 301
body. In contrast, if the nonreducible cross-linker DSS was
used, the 74-kD band was absent and a weak band of im-
munoreactivity was observed at a higher molecular weight
(Fig. 6). This result provides direct evidence that tro-
poelastin is associated with FKBP65 in the secretory path-
way. The ability of the FKBP65 antibody to coimmuno-
precipitate tropoelastin with FKBP65 after cross-linking
was verified by the detection of a tropoelastin doublet in
DSP cross-linked lysates following FKBP65 immunopre-
cipitation (Fig. 6). Because only that amount of tropoelas-
tin in association with FKBP65 would be immunoprecipi-
tated by the FKBP65 antibody following cross-linking, a
relatively weak signal was expected as compared to when
tropoelastin was blotted from a tropoelastin immunopre-
cipitation. To get a strong enough signal, therefore, the
amount of cells used was increased and the ECL times ex-
tended for blots probed with antibodies that differ from
those used for immunoprecipitation (Fig. 6, lanes 2, 3, and
5). When the nonreducible cross-linker DSS was used in-
stead of DSP and the cell lysate immunoprecipitated with
the FKBP65 antibody, no immunoreactive tropoelastin
could be detected on the blot (not shown). This was ex-
pected as the already weak tropoelastin signal would likely
be distributed in several areas of high molecular weight
due to the various complexes formed among tropoelastin,
FKBP65, and other proteins.
Discussion
The present study has identified BiP and FKBP65 as mo-
lecular chaperones for tropoelastin in the secretory path-
way of FBCs using chemical cross-linking in intact cells.
Although in some experiments brefeldin A was used to re-
tain the tropoelastin within the cell and enhance the tro-
poelastin–chaperone interactions, the association of BiP
and FKBP65 with tropoelastin was also shown to occur in
untreated cells. This observation demonstrates that the
tropoelastin–chaperone interactions are physiologically
significant and not a result of distorting the secretory path-
way or disrupting the transport of secreted proteins.
The association of BiP with a secretory protein in the
ER is not surprising. This observation does, however, pro-
vide validity for the cross-linking technique because BiP
and tropoelastin would be in the same compartment dur-
ing the synthesis of tropoelastin and, based on the proper-
ties of BiP as a molecular chaperone (Gething and Sam-
brook, 1992) and the hydrophobic nature of tropoelastin,
it would be highly probable that the two proteins would in-
teract. The association of tropoelastin with FKBP65 is a
novel finding and represents the first ligand to be identi-
fied for an FK506-binding protein in the secretory path-
way. FKBP65 was initially cloned and sequenced from a
JB6 murine epidermal cell cDNA expression library (Coss
et al., 1995) and, to date, represents the sixth FKBP to be
identified. Sequence analysis predicts the protein to con-
tain a potential membrane-spanning region and four PPI-
ase signature domains. FKBP65 was also shown to be a
glycoprotein and to contain a putative signal sequence at
its amino terminus. A potential ER retention sequence at
the COOH terminus (Coss et al., 1995) predicts that FKBP65
is located in the ER. The association of FKBP65 with tro-
poelastin, a soluble secreted protein, provides indirect evi-
dence to support this localization. The extent to which
FKBP65 may move from the ER to other compartments
along the secretory pathway remains to be determined.
Although the predicted molecular mass of FKBP65 is
64,683 D based on the open reading frame of the clone and
60,576 after cleavage of the predicted NH2-terminal signal
sequence (Coss et al., 1995), immunoprecipitation and
Western blotting of bovine FKBP65 revealed a doublet
that migrated at z74 kD by SDS-PAGE. This result is
consistent with the findings of Coss and colleagues (1995)
who suggest that the reason for the decrease in mobility
after SDS-PAGE, results from glycosylation of the protein
and unique protein structure resulting from nine proline–
proline sequences. The reason for migration of the protein
as two bands is more uncertain. The upper band was iden-
tified to be phosphorylated, however, and thus could ac-
count for at least part of the difference (Coss et al., 1995).
The biological role in the ER of the two FKBP PPIases,
FKBP13 (Nigam et al., 1993) and FKBP65, is largely un-
known. Because PPIases are known to catalyze the other-
wise slow conversion between cis- and trans-isomers of
peptidyl–prolyl bonds in peptides and proteins, they have
been assigned the general function of molecular chaper-
ones in that they likely assist in protein folding. Until our
identification of an association between FKBP65 and tro-
poelastin, however, no known ligand for these proteins
had been identified. Although PPIase activity of an FKBP
on a ligand in the ER has not been demonstrated, isomer-
ization of cis- to trans-peptide bonds by a member of the
cyclophilin family of PPIases, cyclophilin B (Smith et al.,
1995), has been shown to be critical for the formation of
the triple helical structure of procollagen. In nascent type I
collagen, it has been estimated that 16% of the X-proline
and 8% of the X-hydroxyproline bonds are in the cis-con-
formation (Sarkar et al., 1984). In order for collagen to as-
semble, all of these bonds must be converted to the trans-
Figure 6. Bovine FKBP65 is
cross-linked to tropoelastin
in the secretory pathway of
FBCs. FBCs were treated
with BFA 1 ALLN for 4 h
before cross-linking with ei-
ther DSP or DSS. Cell lysates
were immunoprecipitated for
either tropoelastin or
FKBP65,  separated by SDS-
PAGE under reducing con-
ditions, transferred, and blot-
ted for either the same protein or the opposite protein. Lane 2
shows that FKBP65 can be detected in the cross-linked cell lysate
after immunoprecipitation with tropoelastin antibody and lane 5
shows that tropoelastin can be detected in the FKBP65 immuno-
precipitation after cross-linking. Note that when the nonreduc-
ible cross-linker is used (lane 3), FKBP65 is detected in a higher
molecular weight complex that must also contain tropoelastin
(arrowhead). This experiment was designed to maximize the abil-
ity to detect the cross-linked proteins and should not be inter-
preted in a quantitative manner because the amount of cell lysate
used was increased threefold for conditions where the blotting
antibody was different than that used for immunoprecipitation.
The ECL exposure times were also adjusted as follows: lanes 1–3,
z30 s; lane 4, z30 s after waiting 2 h for the signal to decay; lane
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conformation. The necessity of this conformational change
was demonstrated by the ability of cyclosporin A, which
competes with procollagen for cyclophilin B, to disrupt the
stability, folding, and assembly of collagen (Steinmann et al.,
1991; Bächinger et al., 1993). Interestingly, FKBP65 shows
a restricted tissue expression (Coss et al., 1995) that is in
contrast to the ubiquitous expression of all other FKBPs.
This observation suggests that FKBP65 may have a spe-
cific role in certain cell types rather than generalized func-
tion as a PPIase.
A role for a protein isomerase in the folding of tro-
poelastin is attractive, based on the fact that z12% of the
residues in tropoelastin are proline. In contrast to procol-
lagen, little is known concerning the conformational state
of these X-proline bonds. The proline residues in tro-
poelastin are, however, in domains within the primary se-
quence that are important for secondary and tertiary
structure of the molecule. In many of these sequences,
proline residues are found at the corner of a b turn that is
stabilized by a hydrogen bond between the C-O of residue
1 and the N-H of residue 4 (Urry, 1983). In order for this
hydrogen bond to form, the proline must be in the trans-
configuration. One important proline-containing sequence
is a pentapeptide, GVGVP, that repeats 11 times near the
center of bovine tropoelastin (Indik et al., 1990). The re-
peating b turns formed by the pentapeptide sequences
stack into a b spiral that itself has interesting mechanical
properties (Urry et al., 1995). By disrupting the b turn sub-
structure, a single cis-proline could alter the formation of
the b spiral and hence prevent the proper folding of tro-
poelastin or alter its elastomeric properties.
Other regions of tropoelastin where PPIase activity may
be important are cross-linking domains that consist of
lysine pairs separated by one or more proline residues and
flanked by additional prolines. Because the presence of
proline residues between and around the lysine residues
destined for cross-linking would place steric restrictions on
the conformation of the cross-linking domains, the activity
of a PPIase on the bonds associated with these prolines
may be of considerable importance for the formation of
the cross-links. On a larger scale, the cis–trans configura-
tion of the X-proline bonds may ultimately play a role in
the overall folding of each monomer, such that cross-link-
ing domains between monomers are aligned.
Whereas the importance of a PPIase to act as a proline
isomerase is obvious, increasing evidence suggests that
these enzymes may play additional, or alternative, roles in
the cell. In Drosophila, the ninaA gene codes for an ER
localized cyclophilin homologue that is specific for photo-
receptor cells. Despite the presence of a potential ER re-
tention signal, ninaA colocalizes with its substrate, Rh1
rhodopsin, in both the ER and in postGolgi secretory vesi-
cles (Colley et al., 1991). Because mutations in the ninaA
gene block the transport of Rh1 rhodopsin to the cell sur-
face and lead to an accumulation of the protein in the ER,
an intracellular trafficking function for ninaA has been
suggested. FKBP52 (also called Hsp56) has also been im-
plicated in a trafficking or targeting event. This PPIase is
present in the cytosol where it binds to Hsp90 and forms a
heterocomplex with untransformed glucocorticoid recep-
tors (Czar et al., 1994; Owens-Grillo et al., 1995). The role
played by FKBP52 in steroid receptor action is uncertain,
particularly because PPIase activity is not required for het-
erocomplex formation nor for proper folding of the hor-
mone-binding domain (Owens-Grillo et al., 1995). Several
lines of evidence, however, including nuclear localization
of FKBP52, have suggested that FKBP52 functions to tar-
get steroid receptor movement to the nucleus rather than
acting as an enzyme (Pratt et al., 1993; Owens-Grillo et al.,
1996). In light of these studies, it will now be important to
determine the extent to which FKBP65 plays a role in the
trafficking of tropoelastin through post-ER compartments
and in the ultimate assembly of the elastic fiber in the ex-
tracellular matrix.
An interesting question is how FKBP65 relates to the
67-kD elastin-binding protein (EBP67) described in ear-
lier studies. EBP67 was originally characterized as a com-
ponent of a protein complex thought to play a role in elas-
tic fiber assembly on the cell surface (Wrenn et al., 1988).
To date, the identity of this protein remains unclear. Can-
didate proteins include the 67-kD high affinity laminin re-
ceptor, galactosyltransferase, 59 nucleotidase, and several
others (for review see Mecham and Hinek, 1996). More
recently, Hinek et al. (1993, 1994, 1995) have suggested
that a catalytically inactive alternatively spliced form of
b-galactosidase is the 67-kD elastin-binding protein and
that this protein functions as an intracellular chaperone.
They propose that this galactosidase variant transports
tropoelastin through the secretory pathway, mediates elas-
tic fiber assembly at the plasma membrane, and then recy-
cles back to the intracellular endosomal compartment
where it reassociates with newly synthesized tropoelastin
and shuttles it to the cell surface (Hinek et al., 1995).
There are fundamental differences between FKBP65 and
the 67-kD protein described by Hinek et al. (1995), how-
ever, that support separate roles for these proteins within
the cell. FKBP65 appears to be localized to early compart-
ments of the secretory pathway consistent with the presence
of a putative ER retention signal. It also does not contain a
lectin-like domain that could interact with galactose-con-
taining glycoconjugates. Furthermore, there is no evidence
that FKBP65 acts to shuttle any protein to the cell surface
and may function solely as a folding chaperone in the ER.
The experiments in the present study were originally de-
signed to investigate whether a “substrate-specific” chap-
erone for tropoelastin is present in cells committed to the
production of elastic fiber components. It seems unlikely
that FKBP65 is specific for tropoelastin, as recent data has
shown several high molecular weight bands that coimmu-
noprecipitate with FKBP65 even in the absence of cross-
linker (Davis, E.C., unpublished observation). Whether
these bands represent additional substrates for FKBP65 or
other molecular chaperones has yet to be determined. Of
particular interest will be to determine if FKBP65 is part
of a “chaperone complex” or whether it acts independently
to assist in the folding and/or trafficking of tropoelastin.
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